# AET06_SMQ variant 1 is produced correctly

    Code
      res
    Output
                                                                    Xanomeline High Dose           Placebo           Xanomeline Low Dose  
                                                                       M            F           M           F           M            F    
                                                                     (N=44)       (N=40)      (N=33)     (N=53)       (N=34)      (N=50)  
      ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one adverse event      4 (9.1%)    7 (17.5%)    3 (9.1%)   6 (11.3%)   4 (11.8%)    2 (4.0%) 
      SMQ 1 (broad)                                                                                                                       
        Total number of patients with at least one adverse event    2 (4.5%)    4 (10.0%)       0       3 (5.7%)     1 (2.9%)    2 (4.0%) 
        Total number of events                                         3            10          0           3           1            4    
          NAUSEA                                                    2 (4.5%)    4 (10.0%)       0       3 (5.7%)     1 (2.9%)    2 (4.0%) 
      AESI                                                                                                                                
        Total number of patients with at least one adverse event    2 (4.5%)    4 (10.0%)    3 (9.1%)   4 (7.5%)     3 (8.8%)        0    
        Total number of events                                         2            7           3           5           4            0    
          HEADACHE                                                  2 (4.5%)    4 (10.0%)    3 (9.1%)   4 (7.5%)     3 (8.8%)        0    

# AET06_SMQ variant 2 is produced correctly

    Code
      res
    Output
                                                                    Xanomeline High Dose           Placebo           Xanomeline Low Dose  
                                                                     >= 65         < 65        >= 65       < 65        >= 65        < 65  
                                                                     (N=73)       (N=11)      (N=72)      (N=14)      (N=76)       (N=8)  
      ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one adverse event     8 (11.0%)    3 (27.3%)    8 (11.1%)   1 (7.1%)    6 (7.9%)        0    
      SMQ 1 (broad)                                                                                                                       
        Total number of patients with at least one adverse event    5 (6.8%)     1 (9.1%)    2 (2.8%)    1 (7.1%)    3 (3.9%)        0    
        Total number of events                                         11           2            2          1            5           0    
          NAUSEA                                                    5 (6.8%)     1 (9.1%)    2 (2.8%)    1 (7.1%)    3 (3.9%)        0    
      AESI                                                                                                                                
        Total number of patients with at least one adverse event    4 (5.5%)    2 (18.2%)    7 (9.7%)       0        3 (3.9%)        0    
        Total number of events                                         7            2            8          0            4           0    
          HEADACHE                                                  4 (5.5%)    2 (18.2%)    7 (9.7%)       0        3 (3.9%)        0    

